Liposomal amphotericin B (Fungisome™) for the treatment of cryptococcal meningitis in HIV/AIDS patients in India: A multicentric, randomized controlled trial

Journal of Postgraduate Medicine

Volumn 56, Issue 2, 2010, Pages 71-75

  Jadhav, M P ^a   Bamba, A ^a   Shinde, V M ^a   Gogtay, N ^a   Kshirsagar, N A ^a   Bichile, L S ^a   Mathai, D ^b   Sharma, A ^c   Varma, S ^d   Digumarathi, R ^e  

^a KEM HOSPITAL   (India)

^b CHRISTIAN MEDICAL COLLEGE   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d Post Graduate Institute of Medical Sciences   (India)

^e NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Amphotericin B; cryptococcal meningitis; HIV Acquired immune deficiency syndrome; liposomes

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE; POTASSIUM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BIOTRANSFORMATION; BLOOD TOXICITY; CHILL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRYPTOCOCCAL MENINGITIS; DRUG COST; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; FUNGUS CULTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOKALEMIA; INDIA; INFUSION RELATED REACTION; LABORATORY TEST; LIVER TOXICITY; MALE; MICROBIOLOGICAL EXAMINATION; MULTICENTER STUDY; NEPHROTOXICITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RIGOR; SIDE EFFECT; TERTIARY HEALTH CARE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CEREBROSPINAL FLUID; CRYPTOCOCCUS NEOFORMANS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; MENINGITIS, CRYPTOCOCCAL; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77954991702     PISSN: 00223859     EISSN: 09722823     Source Type: Journal    
DOI: 10.4103/0022-3859.65276     Document Type: Article

References (19)

1. Dismukes WE. Cryptococcal meningitis in patients with AIDS. J Infect Dis 1988;157:624-628
2. Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989;321:794-799
3. Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ. Cryptococcal disease in patients with acquired immunodeficiency syndrome: Diagnostic features and outcome of treatment. Ann Intern Med 1986;104:234-240
4. Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, et al. Comparison of Amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992;326:83-90.
5. Larsen RA, Leal MA, Chan LS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. Ann Intern Med 1990;113:183-187
6. Gans DJ, Portegies P, Tiessens G, Eeftinck Schattenkerk JK, van Boxtel CJ, van Ketel RJ, et al. Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. AIDS 1992;6:185-190
7. Kshirsagar NA, Panday SK, Kirodian BG, Sanath S. Liposomal drug delivery system from laboratory to clinic. J Postgrad Med 2005;51:S5-16.
8. Gokhale PC, Kotwani RN, Dange SY, Kshirsagar NA, Panday SK. Preclinical and pharmaceutical testing of liposomal amphotericin B. Indian J Med Res Br 1993;98:75-80.
9. Gokhale PC, Kshirsagar NA Panday SK. Development and therapeutic of liposomal amphotericin B. Curr Sci 1993;65:448-454
10. Gokhale PC, Barapatre RJ, Advani SH, Kshirsagar NA Panday SK. Pharmacokinetics and tolerance of amphotericin B in patients. J Antimicrob Chemother 1993;32:133-139
11. Kshirsagar NA, Kirodian BG. Liposomal drug delivery system form laboratory to patients: Our experience. Proc Indian Natl Sci Acad 2002;68:333-348
12. Galgiani JN. Fluconaozle a new antifungal agent. Ann Intern Med 1990;113:177-179
13. Subramanian S, Mathai D. Clinical manifestation and management of cryptococcal infections. J Postgrad Med 2005;51:S21-6.
14. Drutz DJ, Spikard A, Rogers DE, Koeing MG. Treatment of disseminated mycotic infection: A new approach to amphotericin B therapy. Am J Med 1968;45:405-418
15. Leenders AC, Reiss P, Portegies P, Clezy K, HopWim CJ, Hoy J, et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis. AIDS 1997;11:1463-1471
16. Kotwani RN, Gokhale PC, Bodhe PV, Kirodian BG, Kshirsagar NA. Safety and efficacy of liposomal amphotericin B in patients with cryptococcal meningitis. J Assoc Physics India 2001;49:1086-1090
17. Esposito V, Viglietti R, Gargiulo M, Parrella R, Onofrio M, Sangiovanni V, et al. Successful treatment of cryptococcal meningitis with a combination of liposomal amphotericin B, flucytosine and posaconazole: two case reports. In Vivo 2009;23:465-468
18. Sloan D, Dlamini S, Paul N, Dedicoat M. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings. Cochrane Database Syst Rev 2008;8:CD005647.
19. Bodhe PV, Kotwani RN, Kirodian BG, Kshirsagar NA, Pandya SK. Open lable, randomized, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infections. J Assoc Physics India 2002;50:662-670